Women's Health

Latest News

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

March 25th 2025

Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.

Maternal Mortality Due to Cardiovascular Disease More Than Doubles in the US / Image credit: ©interstid - ©interstid - stock.adobe.com
Maternal Mortality Due to Cardiovascular Disease More Than Doubles in the US

March 25th 2025

 More Evidence that Women Face Greater CVD Risk than Men, Even When Baseline Health is Equal
More Evidence that Women Face Greater CVD Risk than Men, Even When Baseline Health is Equal

March 24th 2025

Osteoporosis Risk Screening Tools Fall Short in Younger Postmenopausal Women, New Research Reveals
Osteoporosis Risk Screening Tools Fall Short in Younger Postmenopausal Women, New Research Reveals

March 18th 2025

Women as Young as Age 30 May Experience Perimenopause Symptoms: Daily Dose / image credit: ©New Africa/AdobeStock
Women as Young as Age 30 May Experience Perimenopause Symptoms: Daily Dose

March 12th 2025

Latest CME Events & Activities

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

View More

Community Oncology Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

Community Oncology Connections™: Navigating Early-Stage HR+/HER2- Breast Cancer – Clinical Developments and Innovative Treatments

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

Community Oncology Connections™: Navigating Early-Stage HR+/HER2- Breast Cancer – Clinical Developments and Innovative Treatments | Tennessee

View More

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Kansas

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

May 3, 2025

View More

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

24th Annual International Congress on the Future of Breast Cancer® West

July 18-19, 2025

Register Now!

24th Annual International Congress on the Future of Breast Cancer® East

July 11-12, 2025

Register Now!

Community Practice Connections: 15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

View More

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

View More

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

View More

Community Practice Connections™: 8th Annual School of Nursing Oncology™

View More

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

View More

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

View More

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

View More

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

View More

23rd Annual School of Breast Oncology

November 6-8, 2025

Register Now!

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

More News

© 2025 MJH Life Sciences

All rights reserved.